Oncolytic poxviruses
- 1 March 2012
- journal article
- Published by Allerton Press in Molecular Genetics, Microbiology and Virology
- Vol. 27 (1) , 7-15
Abstract
Modern data on selection and design of poxviruses, which are able to specifically lyse tumor cells of various origins and induce antitumor immunity and apoptosis of malignant cells, are presented in...Keywords
This publication has 57 references indexed in Scilit:
- The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeuticsMicrobes and Infection, 2010
- Giant virus with a remarkable complement of genes infects marine zooplanktonProceedings of the National Academy of Sciences, 2010
- Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SACancer Gene Therapy, 2010
- TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancerGene Therapy, 2010
- Antiangiogenic Arming of an Oncolytic Vaccinia Virus Enhances Antitumor Efficacy in Renal Cell Cancer ModelsJournal of Virology, 2010
- The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivationMolecular Genetics and Genomics, 2009
- Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor modelCancer Gene Therapy, 2009
- Lister strain of vaccinia virus armed with endostatin–angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancerGene Therapy, 2009
- Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase geneCancer Gene Therapy, 2007
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993